Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow  0.00% Nasdaq Up 0.52%
Streaming
Ticker Tape: On

More On ANP.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Antisense Therapeutics Ltd. (ANP.AX)

-ASX
0.14 Up 0.01(3.57%) Apr 24, 1:59AM EDT
Get the big picture on all your investments.
Prev Close:0.14
Open:0.14
Bid:0.14
Ask:0.15
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.14 - 0.16
52wk Range:0.09 - 0.23
Volume:235,759
Avg Vol (3m):518,118
Market Cap:20.89M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Antisense Therapeutics Limited develops and commercializes novel antisense therapeutics in the United States, Canada, Japan, Australia, and Europe. The company’s product pipeline comprises ATL1103, a Phase II clinical trial drug to block grow... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback